These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7495854)

  • 1. Lysophosphatidylcholine inhibits vesicles fusion induced by the NH2-terminal extremity of SIV/HIV fusogenic proteins.
    Martin I; Ruysschaert JM
    Biochim Biophys Acta; 1995 Nov; 1240(1):95-100. PubMed ID: 7495854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.
    Martin I; Defrise-Quertain F; Mandieau V; Nielsen NM; Saermark T; Burny A; Brasseur R; Ruysschaert JM; Vandenbranden M
    Biochem Biophys Res Commun; 1991 Mar; 175(3):872-9. PubMed ID: 2025261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.
    Martin I; Dubois MC; Defrise-Quertain F; Saermark T; Burny A; Brasseur R; Ruysschaert JM
    J Virol; 1994 Feb; 68(2):1139-48. PubMed ID: 8289343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine mediates the mode of insertion of the NH2-terminal SIV fusion peptide into the lipid bilayer.
    Martin I; Dubois MC; Saermark T; Epand RM; Ruysschaert JM
    FEBS Lett; 1993 Nov; 333(3):325-30. PubMed ID: 8224203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry.
    Martin I; Dubois MC; Saermark T; Ruysschaert JM
    Biochem Biophys Res Commun; 1992 Jul; 186(1):95-101. PubMed ID: 1632797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minimal fusion peptide of simian immunodeficiency virus corresponds to the 11 first residues of gp32.
    Lorin A; Lins L; Stroobant V; Brasseur R; Charloteaux B
    J Pept Sci; 2008 Apr; 14(4):423-8. PubMed ID: 17994611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion.
    Epand RF; Martin I; Ruysschaert JM; Epand RM
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1938-43. PubMed ID: 7811285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion.
    Haque ME; Lentz BR
    Biochemistry; 2002 Sep; 41(35):10866-76. PubMed ID: 12196026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
    Martin I; Defrise-Quertain F; Decroly E; Vandenbranden M; Brasseur R; Ruysschaert JM
    Biochim Biophys Acta; 1993 Jan; 1145(1):124-33. PubMed ID: 8422404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes.
    Slepushkin VA; Melikyan GB; Sidorova MS; Chumakov VM; Andreev SM; Manulyan RA; Karamov EV
    Biochem Biophys Res Commun; 1990 Oct; 172(2):952-7. PubMed ID: 2173585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
    Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
    FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of SIV gp32 fusion-peptide single-layer protofibrils as monitored by molecular-dynamics simulations.
    Soto P; Cladera J; Mark AE; Daura X
    Angew Chem Int Ed Engl; 2005 Feb; 44(7):1065-1067. PubMed ID: 15630707
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of lipid vesicle fusion induced by the putative fusion peptide of fertilin (a protein active in sperm-egg fusion) and the NH2-terminal domain of the HIV2 gp41.
    Martin I; Ruysschaert JM
    FEBS Lett; 1997 Apr; 405(3):351-5. PubMed ID: 9108317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the sequence of interactions of the fusion domain of the simian immunodeficiency virus with membranes. Role of the membrane dipole potential.
    Cladera J; Martin I; Ruysschaert JM; O'Shea P
    J Biol Chem; 1999 Oct; 274(42):29951-9. PubMed ID: 10514478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fusion peptide of simian immunodeficiency virus and the phase behaviour of N-methylated dioleoylphosphatidylethanolamine.
    Harroun TA; Balali-Mood K; Gourlay I; Bradshaw JP
    Biochim Biophys Acta; 2003 Oct; 1617(1-2):62-8. PubMed ID: 14637020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
    Buzón V; Cladera J
    Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural study of the interaction between the SIV fusion peptide and model membranes.
    Colotto A; Martin I; Ruysschaert JM; Sen A; Hui SW; Epand RM
    Biochemistry; 1996 Jan; 35(3):980-9. PubMed ID: 8547281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers.
    Li Y; Tamm LK
    Biophys J; 2007 Aug; 93(3):876-85. PubMed ID: 17513369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of membrane fusion by lysophosphatidylcholine.
    Yeagle PL; Smith FT; Young JE; Flanagan TD
    Biochemistry; 1994 Feb; 33(7):1820-7. PubMed ID: 8110784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.